Director of Keros Therapeutics, Inc. (NASDAQ:KROS), Kariv Tomer, buys 60,000 shares worth $3,000,000

According to Keros Therapeutics, Inc.'s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Nov 19 04:39 PM, company Director, Kariv Tomer disclosed buying 60,000 shares at a cost of $50.00. At the time of this transaction (Nov 17), this trade was worth $3,000,000 in total. As of Nov 17, Kariv Tomer now owns 2,288,151 shares in total worth about $159,003,612.98999998.

For the last few recent trades made by Keros Therapeutics, Inc. (NASDAQ:KROS) Director, Kariv Tomer, we have the following information:

Posted by George Daniels on Thursday November 19 2020, 5:58 PM EDT. All trademarks acknowledged. Filed under Business, Stocks. Comments and Trackbacks closed. Follow responses: RSS 2.0